Main Sequence Ventures manages the $240 AUD million CSIRO Innovation Fund that invests in deep tech high growth startups based out of research.
Our Challenges
Reach humanity-
scale healthcare
How do we make high impact equitable, quality healthcare available to everyone?
Feed 10 billion people
How do we feed a booming population without destroying the planet?
Space & New Transport
How will access to space enable new industries? How will transportation change?
Enable the next intelligence leap
How do we help society harness the benefit of, and guard against the threats that new technologies pose?
Supercharge industrial productivity
How do we recharge our industries for the future?
Why We’re Different
Dedicated focus on deep tech companies with global ambitions
Unique deal flow from research relationships and strategy of company creation and spinouts
Experienced team with strong networks for deal flow, talent and coinvestment
Research Excellence
Testing & Certification
Deep Prototyping
Deep Scale Up Facilities
Who is the Fund
Suitable for
The Fund is best suited to wholesale investors who:
- seek investments in early stage, high growth technology companies
- understand and are willing to accept a high level of risk for the potential to generate strong returns
- have an investment horizon greater than 10 years
- seek tax-effective investment strategies
Our Team
Alison Deans
External IC Member
Bill Bartee
Managing Partner
Gabrielle Munzer
Senior Associate
Jack Steele
CSIRO IC Member
Jenny Baxter
Project and Risk Manager
Martin Duursma
Partner
Mike Nicholls
Partner
Mike Zimmerman
Partner
Phil Morle
Partner
Sarah Pearson
External IC Member
Stella Xu
Associate
Virginia Crawter
Senior Legal Counsel
Wholesale & Sophisticated Investors
Register to receive our Fund 2 Information Sheet.
